DNA-RNA Hybrid (S9.6) Mouse Monoclonal Antibody #47099
Product Specifications
| REACTIVITY | All |
| SENSITIVITY | Endogenous |
| MW (kDa) | |
| Source/Isotype | Mouse IgG2a |
Species Cross-Reactivity Key:
- All-All Species Expected
Product Information
Product Usage Information
Dot-blot analysis of R-loops using hybridized DNA-RNA, double-stranded DNA (dsDNA), and double-stranded RNA (dsRNA) species performed according to the detailed protocol published in PMID: 33554969. Briefly:
1. Order oligonucleotides based on PMID: 33554969. Resuspend in annealing buffer at 10 mM Tris (pH 8.0), 50 mM NaCl, and 1 mM EDTA to reach a final concentration of 100 µM.
2. Generate 10 mM hybridized DNA-RNA, dsDNA, and dsRNA species by incubating equimolar amounts of the corresponding oligonucleotides in annealing buffer, heating them up to 95°C for 10 min, and then allowing them to cool slowly to room temperature to allow for reannealing of the strands.
3. Prepare serial dilutions of hybridized oligos at 80, 20, 10, and 4 nM final concentrations prepared in annealing buffer, load 50 mL of each sample into separate wells of the 96-well dot-blot apparatus, then apply to a pre-wet nylon membrane.
4. Apply gentle vacuum pressure to draw solution through the membrane and wrap the mostly dry membrane in plastic wrap.
5. UV cross-link the membrane at 1,200 J/m2 twice using a UV crosslinker.
6. Prepare blocking buffer: 5% milk in Tris-buffered saline with 0.05% Tween 20 (TBST); incubate the membrane in 25 mL of blocking buffer with gentle agitation for 1 hr at room temperature.
7. Wash the membrane three times for 5 min each with 15 mL of 1X TBST, then incubate overnight in primary antibody at 1:1,000 dilution in 10 mL of blocking buffer with gentle agitation at 4°C.
8. Wash the membrane three times for 5 min each with 15 mL of 1X TBST, then incubate with Anti-mouse IgG, HRP-linked Antibody #7076 at 1:2,000 in 10 mL of blocking buffer with gentle agitation for 1 hr at room temperature.
9. Wash the membrane three times for 5 min each with 15 mL of 1X TBST, then develop with enhanced chemiluminescence (ECL) reagents to acquire signals for imaging.
| Application | Dilution |
|---|---|
| Functional | 1:1000 |
Storage
Specificity / Sensitivity
Species Reactivity:
Source / Purification
Background
- Petermann, E. et al. (2022) Nat Rev Mol Cell Biol 23, 521-540.
- Skourti-Stathaki, K. and Proudfoot, N.J. (2014) Genes Dev 28, 1384-96.
- Groh, M. et al. (2014) PLoS Genet 10, e1004318.
- Giannini, M. et al. (2020) PLoS Genet 16, e1009260.
- Yang, X. et al. (2024) Proc Natl Acad Sci USA 121, e2307395120.
- Wells, J.P. et al. (2019) Trends Cancer 5, 619-631.
Limited Uses
Except as otherwise expressly agreed in a writing signed by a legally authorized representative of CST, the following terms apply to Products provided by CST, its affiliates or its distributors. Any Customer's terms and conditions that are in addition to, or different from, those contained herein, unless separately accepted in writing by a legally authorized representative of CST, are rejected and are of no force or effect.
Products are labeled with For Research Use Only or a similar labeling statement and have not been approved, cleared, or licensed by the FDA or other regulatory foreign or domestic entity, for any purpose. Customer shall not use any Product for any diagnostic or therapeutic purpose, or otherwise in any manner that conflicts with its labeling statement. Products sold or licensed by CST are provided for Customer as the end-user and solely for research and development uses. Any use of Product for diagnostic, prophylactic or therapeutic purposes, or any purchase of Product for resale (alone or as a component) or other commercial purpose, requires a separate license from CST. Customer shall (a) not sell, license, loan, donate or otherwise transfer or make available any Product to any third party, whether alone or in combination with other materials, or use the Products to manufacture any commercial products, (b) not copy, modify, reverse engineer, decompile, disassemble or otherwise attempt to discover the underlying structure or technology of the Products, or use the Products for the purpose of developing any products or services that would compete with CST products or services, (c) not alter or remove from the Products any trademarks, trade names, logos, patent or copyright notices or markings, (d) use the Products solely in accordance with CST Product Terms of Sale and any applicable documentation, and (e) comply with any license, terms of service or similar agreement with respect to any third party products or services used by Customer in connection with the Products.